A comprehensive view of respiratory/lung health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna signs 10-year agreement with Australian federal government, Victorian government to work with Monash University to develop mRNA vaccine manufacturing plant; new plant to make up to 100 million respiratory virus vaccines annually
Published: August 17, 2022 by Xinhua News Agency
Seventy percent of patients concerned about tobacco corporations’ ownership of lung disease treatments; treatments include inhalers, medications, other devices
Published: August 16, 2022 by Business Wire
Sanofi, UK National Institute for Health and Care Research enrolling patients for clinical trial to evaluate injectable drug nirsevimab’s protection against respiratory syncytial virus in infants; trial to involve 20,000 infants in UK, France, Germany
Published: August 16, 2022 by SeeNews Pharmaceuticals
Global bronchitis treatment market projected to grow by US$1.1B, have CAGR growth of 4.76%, from 2021 to 2026; growth driven by increase in smoking, as 32.51 million people smoked in US in 2020, 3.7 million smoke in Canada: Technavio
Published: August 02, 2022 by PR Newswire
Novartis cancels filing for FDA approval of tislelizumab to treat non-small cell lung cancer after FDA decision to delay review of drug as esophageal squamous cell carcinoma treatment; Novartis paid BeiGene US$650M for rights to drug outside China
Published: August 02, 2022 by Indian Pharma Industry : Policies

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count